Recipharm AB (publ) (HQ)
Box 603
SE-101 32 Stockholm
Sweden
T: + 46 8 602 52 00
E: info@recipharm.com
W: https://www.recipharm.com/

As a top five CDMO, Recipharm delivers exceptional quality services and products through the entire drug/device combination development and manufacturing journey.

We are at the forefront of drug delivery device innovation, thanks to the heritage of Bespak by Recipharm, which has over 60 years’ experience. We partner with pharma and biotech companies to deliver life-changing medicines, by providing design, development, and manufacture capabilities of innovative drug delivery devices.

Recipharm offers a fully integrated, combination drug product service for developing and manufacturing novel inhalation and intranasal drug delivery , including pressurized metered dose inhalers (pMDIs), soft mist inhalers (SMIs), dry powder inhalers (DPIs), and nasal spray devices. We also deliver market-leading design, development, and manufacture of injectable drug delivery devices, offering a range of auto-injectors utilizing our proprietary VapourSoft^® technology.

Our teams have extensive experience across the whole lifecycle of drug development through to commercial manufacture , building innovations that have the potential to create new treatments and opportunities globally, as well as accelerating routes to market. Working with our customers, we mitigate project risk and work toward successful outcomes that will benefit the healthcare industry and patients.

Recipharm, your one partner for integrated device platform offerings.